Selenium nanoparticles

Where the papers sit

11 papers from the last 6 months study selenium nanoparticles directly · updated from PubMed 12 Oct 2026

• Redox Inflammation and Tissue Protection

  Redox control is the shared therapeutic aim, with selenium formulations used to reduce oxidative stress, glutathione disruption, NF-κB signaling and collagen deposition. Approaches extend from antischistosomal treatment and resveratrol co-delivery in silicosis to protection from H2O2, lead toxicity and osteoarthritis-associated mitochondrial damage. The recurring endpoint is reduced inflammatory or tissue injury across diverse models. Mitochondrial restoration and redox-mediated antifibrotic effects support targeted combination platforms, but cross-disease efficacy remains unresolved.

  5 papers · 45.5%

• Antimicrobial and Antibiofilm Activity

  Plant-extract synthesis is being paired with physicochemical characterization and antimicrobial testing. Activity recurs against Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli and Candida albicans, with particular emphasis on biofilm inhibition. FTIR spectroscopy, surface charge and related measurements are used to connect particle properties with biological effects. The work remains preclinical, seeking reproducible green formulations rather than establishing clinical antimicrobial use.

  2 papers · 18.2%

• Others — Selenium Stress Responses

  Protective selenium use spans γ-radiation injury, periparturient stress, dialysis membranes and Orobanche damage in chickpea. Molecular work emphasizes HSP60, HSP70 and HSP90 regulation and comparison with sodium selenite, whereas engineering work embeds particles in PLA membranes. The common direction is mitigation of stress or toxicity rather than treatment of one shared disease. Because endpoints range from serum selenium and heat-shock responses to membrane function and plant growth, no unified therapeutic trajectory is established.

  4 papers · 36.4%